Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuntao Liu

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Zhonghua Nei Ke Za Zhi|December 18, 2015
[An epidemiological survey on management and insights of asthma in China in 2009 to 2010]Nan Su, Jiangtao Lin, Guoliang Liu, et al.
Journal of Psychiatry and Brain Science|December 10, 2021
Children and Adolescents' Psychological Well-Being Became Worse in Heavily Hit Chinese Provinces during the COVID-19 EpidemicJing Ma, Jun Ding, Jiawen Hu, et al.
Zhonghua Nei Ke Za Zhi|November 8, 2014
[An epidemiological survey of current asthma control status in China]Nan Su, Jiangtao Lin, Guoliang Liu, et al.
The American Journal of Gastroenterology|April 7, 2025
Efficacy of Polysaccharide Hemostatic Powder on Blood Oozing Among Patients With Postendoscopic Sphincterotomy Bleeding: A Randomized Controlled TrialHengcun Li, Jiaxuan Zuo, Wenhai Wang, et al.
Zhonghua Yi Xue Za Zhi|June 14, 2014
[Risk factors of bronchial asthma among people aged over 14 years in China]Xiaokai Feng, Jiangtao Lin, Nan Su, et al.
Frontiers in Public Health|February 1, 2021
Serious Workplace Violence Against Healthcare Providers in China Between 2004 and 2018Jing Ma, Xi Chen, Qiongjuan Zheng, et al.
Respiratory Medicine|April 2, 2018
Prevalence and risk factors of asthma in mainland China: The CARE studyJiangtao Lin, Wenya Wang, Ping Chen, et al.
Chest|March 27, 2026
Efficacy and Safety of Ensifentrine in Chinese Patients with Chronic Obstructive Pulmonary Disease: The ENHANCE-CHINA Randomized Clinical TrialYumin Zhou, Charlie Chen, Zihui Wang, et al.
Allergy, Asthma & Immunology Research|December 4, 2025
Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 TrialKefang Lai, Zhijun Yan, Donghua Qian, et al.
Respiratory Medicine|July 6, 2021
Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in ChinaMin Zhang, Meiling Jin, Xin Zhou, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Zhonghua Nei Ke Za Zhi|December 18, 2015
[An epidemiological survey on management and insights of asthma in China in 2009 to 2010]Nan Su, Jiangtao Lin, Guoliang Liu, et al.
Journal of Psychiatry and Brain Science|December 10, 2021
Children and Adolescents' Psychological Well-Being Became Worse in Heavily Hit Chinese Provinces during the COVID-19 EpidemicJing Ma, Jun Ding, Jiawen Hu, et al.
Zhonghua Nei Ke Za Zhi|November 8, 2014
[An epidemiological survey of current asthma control status in China]Nan Su, Jiangtao Lin, Guoliang Liu, et al.
The American Journal of Gastroenterology|April 7, 2025
Efficacy of Polysaccharide Hemostatic Powder on Blood Oozing Among Patients With Postendoscopic Sphincterotomy Bleeding: A Randomized Controlled TrialHengcun Li, Jiaxuan Zuo, Wenhai Wang, et al.
Zhonghua Yi Xue Za Zhi|June 14, 2014
[Risk factors of bronchial asthma among people aged over 14 years in China]Xiaokai Feng, Jiangtao Lin, Nan Su, et al.
Frontiers in Public Health|February 1, 2021
Serious Workplace Violence Against Healthcare Providers in China Between 2004 and 2018Jing Ma, Xi Chen, Qiongjuan Zheng, et al.
Respiratory Medicine|April 2, 2018
Prevalence and risk factors of asthma in mainland China: The CARE studyJiangtao Lin, Wenya Wang, Ping Chen, et al.
Chest|March 27, 2026
Efficacy and Safety of Ensifentrine in Chinese Patients with Chronic Obstructive Pulmonary Disease: The ENHANCE-CHINA Randomized Clinical TrialYumin Zhou, Charlie Chen, Zihui Wang, et al.
Allergy, Asthma & Immunology Research|December 4, 2025
Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 TrialKefang Lai, Zhijun Yan, Donghua Qian, et al.
Respiratory Medicine|July 6, 2021
Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in ChinaMin Zhang, Meiling Jin, Xin Zhou, et al.
Pageof 9